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Surg. 2003;126:777-82.Use of a polytetrafluoroethylene graft to prevent recurrence of
saphenous vein graft aneurysm after coronary artery bypass graftingSyed T. Hussain, MD, Nicholas G. Smedira, MD, and Eric E. Roselli, MD, Cleveland, OhioDilatation of vein grafts occurs in 14% of patients within 14
years after coronary artery bypass grafting (CABG), but is
rarely of concern.1 Saphenous vein graft (SVG) aneurysm
(SVGA), however, is a potentially fatal complication.2,3 In
a recent retrospective analysis, only 16 patients underwent
surgical repair of SVGAs during a 30-year interval in which
28,603 patients underwent CABG.4 Recurrence of SVGA
after reoperation is unknown. Theoretically, the risk re-
mains, because the conditions for development of this com-
plication are unchanged.We describe a novel techniquewith
a polytetrafluoroethylene graft to encapsulate the new vein
graft and avoid late aneurysmal degeneration.
CLINICAL SUMMARY
A 66-year-old man underwent CABG in 1993, with sep-
arate SVGs to the obtuse marginal artery (OM) and the pos-
terior descending artery (PDA) and a left internal thoracic
artery graft to the left anterior descending coronary artery.
He had a history of bilateral popliteal artery aneurysms
that were stented. Twelve years after this operation, during
a workup for dizziness, he had a coronary angiogram that
showed aneurysmal dilatation of his vein grafts. He was
started on warfarin, and no other intervention was per-
formed. He came to us 5 years later with new, recurring sub-
sternal chest pain. A repeated coronary angiogram showed
a dilated yet patent vein graft to the OM. The right graft
could not be engaged during the angiogram. Computedtomography of the chest showed diffuse aneurysms of
both the OM and PDAvein grafts, with maximum diameters
of 3.1 and 5 cm, respectively (Figure 1).FIGURE 1. Preoperative computed tomographic scan showing large
pseudoaneurysm of saphenous vein graft to the right coronary artery (A)
and to the obtuse marginal artery (B).
gery c June 2013
FIGURE 2. A, Intraoperative photograph demonstrating the polytetra-
fluoroethylene graft sleeve over the aortocoronary bypass graft. B, Recon-
structed computed tomographic angiogram showing the patent and normal
aortocoronary bypass graft.
Surgical TechniquesReoperative median sternotomy was performed. After
adhesiolysis, cannulation was performed through the as-
cending aorta and superior vena cava with a 3-stage can-
nula to avoid manipulation of the SVGAs. After cardiac
arrest, the SVGA to the PDA was transected proximally,
the aneurysm was opened, and distal anastomosis of the
new SVG to the PDA was performed. A 6-mm ringed pol-
ytetrafluoroethylene graft was placed as a sleeve over the
new SVG, and the proximal anastomosis was completed
(Figure 2, A). The OM graft aneurysm was resected, and
a free right internal thoracic artery graft was used as
a replacement. The patient had an uneventful recovery.
Eighteen months after surgery, computed tomographyThe Journal of Thoracic and Carshowed a patent and normal vein graft with no aneurysmal
degeneration (Figure 2, B).
DISCUSSION
SVGAs are rare,1,4,5 but their prevalence is underestimated
because many patients are symptom free. Etiology is
incompletely understood, and atherosclerosis, surgical
technique, and infection have been implicated.4,5 The
vicinity of the venous valves may be intrinsically weak
because of lack of circular muscle, and veins may also be
weakened at branching sites or in areas damaged by initial
surgical procedures.4,5 There may also be a possible
association with connective tissue disorders, as our patient
also had bilateral popliteal aneurysms and later had
SVGAs develop.
SVGA usually presents with chest pain,3,4 but it may also
present with rupture, compression of surrounding structures,
fistula formation, or myocardial infarction.1,4,5 The triad of
chest pain, mediastinal mass, and previous CABG should
raise concern about the diagnosis. Suspected SVGA should
be evaluated with computed tomography or magnetic
resonance imaging of the chest and coronary angiography
to delineate pathoanatomy and determine patency or other
coronary stenoses.
Surgical resection of the aneurysm and revascularization
has been the most common strategy used. Percutaneous in-
terventions have been reported more recently, with 16% of
cases treated by these methods.5
To avoid later aneurysmal degeneration, we covered our
new vein graft with the polytetrafluoroethylene graft
material and used the internal thoracic artery to replace
the circumflex graft. This technique, which has not been de-
scribed for managing SVGA, has proved to be stable, and
grafts are patent at 18 months of follow-up. Because this
patient population may be more vulnerable to aneurysmal
degeneration of the SVG, the use of a polytetrafluoroethy-
lene graft to encapsulate the SVG should be considered
during these complex reoperations.References
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